Literature DB >> 20680390

Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function.

Amanda L Getty1, David A Pearce.   

Abstract

Neuronal ceroid lipofuscinoses (NCL) are caused by mutations in eight different genes, are characterized by lysosomal accumulation of autofluorescent storage material, and result in a disease that causes degeneration of the central nervous system (CNS). Although functions are defined for some of the soluble proteins that are defective in NCL (cathepsin D, PPT1, and TPP1), the primary function of the other proteins defective in NCLs (CLN3, CLN5, CLN6, CLN7, and CLN8) remain poorly defined. Understanding the localization and network of interactions for these proteins can offer clues as to the function of the NCL proteins and also the pathways that will be disrupted in their absence. Here, we present a review of the current understanding of the localization, interactions, and function of the proteins associated with NCL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20680390      PMCID: PMC4120758          DOI: 10.1007/s00018-010-0468-6

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  219 in total

Review 1.  Functional roles of Na,K-ATPase subunits.

Authors:  Käthi Geering
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-09       Impact factor: 2.894

2.  Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL.

Authors:  Zhongjian Zhang; Yi-Ching Lee; Sung-Jo Kim; Moonsuk S Choi; Pei-Chih Tsai; Yan Xu; Yi-Jin Xiao; Peng Zhang; Alison Heffer; Anil B Mukherjee
Journal:  Hum Mol Genet       Date:  2005-12-20       Impact factor: 6.150

3.  Different patterns of hydrophobic protein storage in different forms of neuronal ceroid lipofuscinosis (NCL, Batten disease).

Authors:  D N Palmer; R D Jolly; H C van Mil; J Tyynelä; V J Westlake
Journal:  Neuropediatrics       Date:  1997-02       Impact factor: 1.947

4.  CRMP-2 induces axons in cultured hippocampal neurons.

Authors:  N Inagaki; K Chihara; N Arimura; C Ménager; Y Kawano; N Matsuo; T Nishimura; M Amano; K Kaibuchi
Journal:  Nat Neurosci       Date:  2001-08       Impact factor: 24.884

5.  CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.

Authors:  K Luiro; O Kopra; M Lehtovirta; A Jalanko
Journal:  Hum Mol Genet       Date:  2001-09-15       Impact factor: 6.150

6.  Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis.

Authors:  E Hellsten; J Vesa; V M Olkkonen; A Jalanko; L Peltonen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

7.  Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice.

Authors:  Tuhin Virmani; Praveena Gupta; Xinran Liu; Ege T Kavalali; Sandra L Hofmann
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

8.  Intracellular calcium modulates the nuclear translocation of calsenilin.

Authors:  Nikhat F Zaidi; Emma E Thomson; Eun-Kyoung Choi; Joseph D Buxbaum; Wilma Wasco
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

9.  Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis.

Authors:  Sabrina Jabs; Arne Quitsch; Reijo Käkelä; Bettina Koch; Jaana Tyynelä; Helmut Brade; Markus Glatzel; Steven Walkley; Paul Saftig; Marie T Vanier; Thomas Braulke
Journal:  J Neurochem       Date:  2008-05-21       Impact factor: 5.372

10.  Revelation of a novel CLN5 mutation in early juvenile neuronal ceroid lipofuscinosis.

Authors:  N Cannelli; N Nardocci; D Cassandrini; M Morbin; C Aiello; M Bugiani; L Criscuolo; F Zara; P Striano; T Granata; E Bertini; A Simonati; F M Santorelli
Journal:  Neuropediatrics       Date:  2007-02       Impact factor: 1.947

View more
  29 in total

1.  Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.

Authors:  Attila D Kovács; Angelika Saje; Andrew Wong; Serena Ramji; Jonathan D Cooper; David A Pearce
Journal:  Neuropharmacology       Date:  2012-06-06       Impact factor: 5.250

Review 2.  Large animal models for Batten disease: a review.

Authors:  Krystal Weber; David A Pearce
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

3.  Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.

Authors:  Carolin Seifert; Stephan Storch; Robert Bähring
Journal:  J Biol Chem       Date:  2020-07-07       Impact factor: 5.157

4.  The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking.

Authors:  Susan L Cotman; John F Staropoli
Journal:  Clin Lipidol       Date:  2012-02

5.  Screening for calcium channel modulators in CLN3 siRNA knock down SH-SY5Y neuroblastoma cells reveals a significant decrease of intracellular calcium levels by selected L-type calcium channel blockers.

Authors:  Kristina An Haack; Srinivas B Narayan; Haying Li; Ashley Warnock; Lu Tan; Michael J Bennett
Journal:  Biochim Biophys Acta       Date:  2010-10-07

6.  Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).

Authors:  Megan E Bosch; Amy Aldrich; Rachel Fallet; Jessica Odvody; Maria Burkovetskaya; Kaitlyn Schuberth; Julie A Fitzgerald; Kevin D Foust; Tammy Kielian
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

Review 7.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 8.  The genetics of dystonias.

Authors:  Mark S LeDoux
Journal:  Adv Genet       Date:  2012       Impact factor: 1.944

Review 9.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

10.  CLN6 p.I154del mutation causing late infantile neuronal ceroid lipofuscinosis in a large consanguineous Moroccan family.

Authors:  Ahmed Bouhouche; Wafae Regragui; Elmostafa El Fahime; Naima Bouslam; Rachid Tazi-Ahnini; Marouane Melloul; Ali Benomar; Mohamed Yahyaoui
Journal:  Indian J Pediatr       Date:  2012-11-22       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.